Adenovirus protein VII binds the A-box of HMGB1 to repress interferon responses.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
09 2023
Historique:
received: 18 04 2023
accepted: 23 08 2023
revised: 25 09 2023
medline: 26 9 2023
pubmed: 13 9 2023
entrez: 13 9 2023
Statut: epublish

Résumé

Viruses hijack host proteins to promote infection and dampen host defenses. Adenovirus encodes the multifunctional protein VII that serves both to compact viral genomes inside the virion and disrupt host chromatin. Protein VII binds the abundant nuclear protein high mobility group box 1 (HMGB1) and sequesters HMGB1 in chromatin. HMGB1 is an abundant host nuclear protein that can also be released from infected cells as an alarmin to amplify inflammatory responses. By sequestering HMGB1, protein VII prevents its release, thus inhibiting downstream inflammatory signaling. However, the consequences of this chromatin sequestration on host transcription are unknown. Here, we employ bacterial two-hybrid interaction assays and human cell culture to interrogate the mechanism of the protein VII-HMGB1 interaction. HMGB1 contains two DNA binding domains, the A- and B-boxes, that bend DNA to promote transcription factor binding while the C-terminal tail regulates this interaction. We demonstrate that protein VII interacts directly with the A-box of HMGB1, an interaction that is inhibited by the HMGB1 C-terminal tail. By cellular fractionation, we show that protein VII renders A-box containing constructs insoluble, thereby acting to prevent their release from cells. This sequestration is not dependent on HMGB1's ability to bind DNA but does require post-translational modifications on protein VII. Importantly, we demonstrate that protein VII inhibits expression of interferon β, in an HMGB1-dependent manner, but does not affect transcription of downstream interferon-stimulated genes. Together, our results demonstrate that protein VII specifically harnesses HMGB1 through its A-box domain to depress the innate immune response and promote infection.

Identifiants

pubmed: 37703278
doi: 10.1371/journal.ppat.1011633
pii: PPATHOGENS-D-23-00671
pmc: PMC10519595
doi:

Substances chimiques

Interferons 9008-11-1
HMGB1 Protein 0
Nuclear Proteins 0
Chromatin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1011633

Subventions

Organisme : NIGMS NIH HHS
ID : R00 GM134153
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM133441
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI083203
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

Copyright: © 2023 Arnold et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Gen Virol. 1989 Dec;70 ( Pt 12):3225-34
pubmed: 2691633
Biochemistry. 1998 Feb 24;37(8):2673-81
pubmed: 9485418
Annu Rev Virol. 2019 Sep 29;6(1):177-197
pubmed: 31283442
Proc Natl Acad Sci U S A. 1976 Feb;73(2):401-4
pubmed: 1061143
J Mol Biol. 2008 Dec 31;384(5):1262-72
pubmed: 18948112
Sci Rep. 2017 Apr 24;7:46683
pubmed: 28436474
BMC Res Notes. 2010 Nov 10;3:294
pubmed: 21067583
Dev Cell. 2021 Aug 9;56(15):2145-2159.e7
pubmed: 34242584
Curr Opin Genet Dev. 2003 Apr;13(2):170-8
pubmed: 12672494
Cell Host Microbe. 2012 Jun 14;11(6):597-606
pubmed: 22704620
Front Immunol. 2020 Mar 20;11:484
pubmed: 32265930
Exp Cell Res. 2006 Nov 1;312(18):3526-38
pubmed: 16962095
Biochim Biophys Acta. 2010 Jan-Feb;1799(1-2):101-13
pubmed: 20123072
J Biol Chem. 2002 Mar 1;277(9):7157-64
pubmed: 11748232
J Virol. 2005 Feb;79(4):2474-83
pubmed: 15681448
FEBS Lett. 2017 Jan;591(2):282-294
pubmed: 28027393
Mol Cell Proteomics. 2010 Jan;9(1):117-30
pubmed: 19812395
Biochim Biophys Acta. 1982 Jan 26;696(1):76-86
pubmed: 7082670
Gene. 2007 Jan 31;387(1-2):133-40
pubmed: 17156942
Sci Rep. 2013;3:1812
pubmed: 23657240
EMBO J. 1992 Mar;11(3):1055-63
pubmed: 1547772
FEBS Lett. 2019 Dec;593(24):3484-3495
pubmed: 31721176
Curr Biol. 2021 Dec 6;31(23):5227-5237.e7
pubmed: 34666003
PLoS Pathog. 2020 Nov 24;16(11):e1009018
pubmed: 33232373
Cell Death Differ. 2014 Aug;21(8):1229-39
pubmed: 24769733
J Virol. 2017 Sep 27;91(20):
pubmed: 28794020
Proc Natl Acad Sci U S A. 1998 May 12;95(10):5752-6
pubmed: 9576956
Nucleic Acids Res. 2009 Jun;37(10):3153-64
pubmed: 19304746
Am J Physiol Cell Physiol. 2003 Apr;284(4):C870-9
pubmed: 12620891
Nucleic Acids Res. 2011 Feb;39(3):889-901
pubmed: 20926393
Front Immunol. 2017 Mar 02;8:209
pubmed: 28303139
PLoS One. 2015 Sep 02;10(9):e0137102
pubmed: 26332038
Virology. 1983 Jul 30;128(2):480-4
pubmed: 6310869
Immunity. 2018 Oct 16;49(4):740-753.e7
pubmed: 30314759
J Biol Chem. 1998 Apr 24;273(17):10355-61
pubmed: 9553091
Pathogens. 2023 Mar 10;12(3):
pubmed: 36986359
Nature. 2017 Sep 21;549(7672):394-398
pubmed: 28902841
Antiviral Res. 2023 Feb;210:105487
pubmed: 36657882
Viruses. 2021 Feb 28;13(3):
pubmed: 33671079
J Virol. 2004 Jun;78(12):6459-68
pubmed: 15163739
Cell. 2021 Jan 7;184(1):76-91.e13
pubmed: 33147444
Biochemistry. 2003 Mar 11;42(9):2664-71
pubmed: 12614161
J Virol. 1987 Oct;61(10):3335-9
pubmed: 3625842
Int J Mol Sci. 2021 Jun 29;22(13):
pubmed: 34209806
ACS Omega. 2022 Oct 05;7(41):36825-36835
pubmed: 36278084
PLoS Pathog. 2017 Jun 19;13(6):e1006455
pubmed: 28628648
J Immunol. 2009 May 1;182(9):5800-9
pubmed: 19380828
J Mol Biol. 2016 Oct 9;428(20):4060-4072
pubmed: 27558111
Nucleic Acids Res. 2005 Feb 24;33(4):e36
pubmed: 15731329
Bio Protoc. 2017 Mar 20;7(6):
pubmed: 28845440
Virology. 2006 Aug 1;351(2):291-302
pubmed: 16678874
Nature. 2009 Nov 5;462(7269):99-103
pubmed: 19890330
J Biol Chem. 1984 Nov 25;259(22):13980-5
pubmed: 6094534
Nucleic Acids Res. 2019 Sep 26;47(17):9231-9242
pubmed: 31396624
J Virol. 2007 May;81(9):4744-52
pubmed: 17301128
Redox Biol. 2021 Apr;40:101858
pubmed: 33461096
Exp Mol Med. 2022 Feb;54(2):91-102
pubmed: 35217834
J Virol. 2012 Sep;86(17):9122-33
pubmed: 22696656
Mol Aspects Med. 2014 Dec;40:1-116
pubmed: 25010388
Biochemistry. 2004 Sep 28;43(38):11992-7
pubmed: 15379539
Genes Dev. 2001 Dec 1;15(23):3104-17
pubmed: 11731475
Nucleic Acids Res. 1983 Jan 25;11(2):441-60
pubmed: 6828374
Genes Dev. 1998 Feb 15;12(4):462-72
pubmed: 9472015
Viruses. 2022 Nov 23;14(12):
pubmed: 36560611
J Cell Sci. 2016 Jan 1;129(1):29-38
pubmed: 26567221
Nature. 1977 Jun 9;267(5611):552-4
pubmed: 876376
J Virol. 1976 Feb;17(2):462-71
pubmed: 1255847
Nature. 2002 Jul 11;418(6894):191-5
pubmed: 12110890
Nature. 2016 Jul 7;535(7610):173-7
pubmed: 27362237
Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11942-7
pubmed: 20547845
J Mol Biol. 2010 Nov 12;403(5):706-22
pubmed: 20691192
PLoS One. 2013 Nov 08;8(11):e79572
pubmed: 24255708
J Mol Biol. 2007 Dec 14;374(5):1286-97
pubmed: 17988686
Sci Rep. 2019 Jan 31;9(1):1039
pubmed: 30705303
EMBO J. 2003 Oct 15;22(20):5551-60
pubmed: 14532127
J Virol. 2006 Jan;80(2):794-801
pubmed: 16378981
Microbiol Mol Biol Rev. 2016 Nov 30;81(1):
pubmed: 27903656

Auteurs

Edward A Arnold (EA)

Department of Microbiology, University of Washington, Seattle, Washington, United States of America.

Robin J Kaai (RJ)

Molecular & Cellular Biology, Graduate Program, University of Washington, Seattle, Washington, United States of America.

Katie Leung (K)

Department of Microbiology, University of Washington, Seattle, Washington, United States of America.

Mia R Brinkley (MR)

Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.

Laurel E Kelnhofer-Millevolte (LE)

Medical Scientist Training Program, University of Washington, Seattle, Washington, United States of America.

Monica S Guo (MS)

Department of Microbiology, University of Washington, Seattle, Washington, United States of America.

Daphne C Avgousti (DC)

Department of Microbiology, University of Washington, Seattle, Washington, United States of America.
Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH